Article Information
History
- April 13, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Awadhesh Kumar Singh, MD, DM1,*,
- Sanjeev Ratnakar Phatak, MD2,
- Nagendra Kumar Singh, MD3,
- Arvind Gupta, MD4,
- Arvind Sharma, MD5,
- Kingshuk Bhattacharjee, PhD6 and
- Ritu Singh, MD7
- 1Consultant Endocrinologist, G. D Hospital & Diabetes Institute, Kolkata, West Bengal, India
- 2Consultant Physician & Diabetologist, Vijayratna Diabetes Centre, Ahmedabad, Gujarat, India
- 3Director, Diabetes and Heart Research Centre, Dhanbad, Jharkhand, India
- 4Head, Department of Diabetes, Obesity and Metabolic Disorders, Rajasthan Hospital, Jaipur, Rajasthan, India
- 5Associate Professor, Dept. of Community Medicine, Mahatma Gandhi Medical College & Hospital, Jaipur, Rajasthan, India
- 6Independent Biostatistician, Kolkata, West Bengal, India
- 7Consultant Gynecologists, G. D Hospital & Diabetes Institute, Kolkata, West Bengal, India
- ↵*Corresponding Author:
A. K. Singh, G.D Hospital & Diabetes Institute, Kolkata - 700013, India; e mail: draksingh_2001{at}yahoo.com, drawadheshkumarsingh{at}gmail.com; Phone:091 9831020428
Posted April 13, 2021.
Antibody Response after First-dose of ChAdOx1-nCOV (Covishield™®) and BBV-152 (Covaxin™®) amongst Health Care Workers in India: Preliminary Results of Cross-sectional Coronavirus Vaccine-induced Antibody Titre (COVAT) study
